Form 8-K - Current report:
SEC Accession No. 0001437749-24-034898
Filing Date
2024-11-13
Accepted
2024-11-13 16:05:36
Documents
18
Period of Report
2024-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K aytu20240909_8k.htm   iXBRL 8-K 42933
2 EXHIBIT 10.1 ex_745344.htm EX-10.1 77415
3 EXHIBIT 99.1 ex_722664.htm EX-99.1 295424
8 logo01.jpg GRAPHIC 3651
9 logo.jpg GRAPHIC 4381
  Complete submission text file 0001437749-24-034898.txt   614838

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aytu-20241111.xsd EX-101.SCH 3410
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aytu-20241111_def.xml EX-101.DEF 11808
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20241111_lab.xml EX-101.LAB 15859
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20241111_pre.xml EX-101.PRE 12023
20 EXTRACTED XBRL INSTANCE DOCUMENT aytu20240909_8k_htm.xml XML 2947
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 241454063
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)